Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,901.10down ₹21.80 (1.13%)BSE ₹1,896.10
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,922.90.
30 Oct: open ₹1,923.00, high ₹1,932.90, low ₹1,872.00
52-week range of traded prices to 30 Oct 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,891 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.53
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.25
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,06,69638.4% delivered
Wockhardt credit ratings
28 filed, newest first.
May 2026
21 May · Rating
Aug 2025
26 Aug · Rating
May 2024
16 May · Rating
15 May · Rating
Sep 2023
5 Sep · Rating
Jun 2023
7 Jun · Rating
Dec 2022
22 Dec · Rating
Sep 2022
5 Sep · Rating
Sep 2021
30 Sep · Rating
3 Sep · Rating
Apr 2021
6 Apr · Rating
Oct 2020
1 Oct · Rating
Aug 2020
27 Aug · Rating
Sep 2019
30 Sep · Rating
Aug 2019
28 Aug · Rating
Mar 2019
29 Mar · Rating
Oct 2018
19 Oct · Rating
12 Oct · Rating
May 2018
15 May · Rating
Mar 2018
30 Mar · Rating
Feb 2018
Jan 2016
Dec 2015
Nov 2015
Apr 2015
Feb 2014
7 Feb · Rating
Credit Analysis & Research Limited (CARE) has assigned a 'CARE A1+' (A One Plus) rating to the short term facilities of the Company, having a tenure upto one year. Instruments with this rating are considered to have a strong degree of safety regarding timely payment of financial obligations and carry lowest credit risk. Further, CARE has assigned a 'CARE AA-' (Double A minus) rating to Company's long term facilities. Instruments with this ratings are considered to have a high degree of safety regarding timely servicing of financial obligations and such instruments carry very low credit risk.